Loss of CRBN expression in cancer cells is a common problem for CRBN-recruited PROTACs; downregulation of CRBN upregulates AMPK activity, suggesting acceleration of immunogenic cell death in these cancer cells [48–50]. The gene discussed is CRBN; the disease is cancer.